Pharmaceuticals News
-
Zimbabwe eyes Egyptian medicine
The MoU signing was done by the Medicines Control Authority of Zimbabwe (MCAZ) and the Egypt Drug Authority (EDA).
-
Kahira Pharmaceuticals’ profits fall 62.9% in 9 months: Egypt
Kahira Pharmaceuticals is an Egypt-based company involved in the manufacture and trade of pharmaceutical products.
-
Egypt, Portugal ink health cooperation protocol
Under the agreement, health sectors in both countries will exchange expertise and information.
-
The Sovereign Fund of Egypt acquires 49% in El-Ezaby Pharmacy
El-Ezaby will utilize the investment to increase its branch count to almost 600.
-
Egypt sovereign fund and private sector partner to launch B2B pharma venture
The healthcare subfund of The Sovereign Fund of Egypt (TSFE) and B Investments company have entered into a partnership with El-Ezaby pharmacy.
-
How Pfizer Centers Patients and Healthcare Professionals in Egypt
Over the past ten years, Egypt’s healthcare sector has seen increased investment appetite, and the private sector has historically played a large role
-
Egypt: Minapharm Pharmaceuticals’ shareholders nod to 2022 dividends
The ordinary general meeting (OGM) approved the announced dividends on 26 April 2023, according to a bourse disclosure.
-
Egypt discussing $80 mln pharmaceutical raw materials project with Indian investors
Egyptian government announced that talks are underway with local and Indian investors launching projects to manufacture pharmaceutical raw material.
-
DPI and Amethis Co-Invest in Marcyrl
Development Partners International (DPI) and Amethis have co-invested in Marcyrl Pharmaceutical Industries, an Egyptian pharmaceuticals manufacturer.
-
Macro Group targets EGP 1bn in sales this year
The increase in the market share will be achieved by adding new products to its list of products, which currently number more than 143 products.
-
EIPICO’s shareholders approve 2022 dividends, capital increase
The extraordinary general meeting of EIPICO, which was held on 1 April 2023, approved a 50% capital raise.
-
GSK Egypt records 376% leap in 2022 consolidated profits
GlaxoSmithKline (GSK Egypt) witnessed 376% higher consolidated net profits after tax at EGP 735 million in 2022, compared to EGP 155 million in 2021.
-
Minapharm’s net profits grow 31.36% YoY in 2022
Consolidated revenues amounted to EGP 3.620 billion last year, up from EGP 3.005 billion in 2021.
-
Egypt to build 5 factories for pharmaceutical raw materials
The yet-to-be-established factories would produce up to 100 pharmaceutical raw items until 2025.
-
Novartis commends Egyptian government’s efforts in enhancing healthcare services
The Egyptian government spares no effort in providing the best medical service to Egyptian women in accordance with international standards.
-
Health Ministry receive over 2mln doses of ‘modified’ Pfizer vaccine for COVID-19
Abdel Ghaffar added that the shipments will be distributed to vaccination centres spread across all governorates of the republic.
-
Egypt’s SEDICO Pharmaceutical starts operations at new cancer drugs factory
The company self-funded 70 percent of the investment in the new factory with bank loans accounting for the remaining 30 percent.
-
Zimbabwe signs deals with pharmaceuticals in Egypt
The Zimbabwe government has struck a deal with 10 pharmaceutical companies from Egypt to provide medicine to the country’s hospital.
-
Minapharm Pharmaceuticals mulls $19.48mln capital hike
Under the board’s recommendation, a total of 60.29mln bonus shares will be distributed, where each shareholder will receive 5.11 bonus shares.
-
Egypt to establish partnerships with private sector in pharmaceuticals
Egypt is currently under a $3 billion deal loan with the IMF extending through FY2025/2026.